Announcements Trials
Browse Landscape

Phase

Phase NA 12Phase 1 4Phase 3 3Phase 2 2Phase 1/2 2Phase 2/3 1

Status

Terminated 1Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4Thoracic 1Myeloid 1Genitourinary 1Classical hematology 1CNS 1

Conditions

Hematologic Neoplasms 4Myelodysplastic Syndromes 1Monoclonal Gammopathy of Undetermined Significance 1Heart Failure 1Cardiomyopathies 1Anemia, Aplastic 1

Interventions

Cytarabine 184Cyclophosphamide 176fludarabine 146Azacitidine 121venetoclax 115fludarabine phosphate 104Rituximab 80Decitabine 74Filgrastim 58Specimen Handling 55Etoposide 55Lenalidomide 47Biopsy 45Dexamethasone 41Methotrexate 40Bortezomib 40Mitoxantrone 39Granulocyte Colony-Stimulating Factor 39Daunorubicin 39Vincristine 37Melphalan 36ibrutinib 35Tacrolimus 35Dasatinib 34Whole-Body Irradiation 32Clofarabine 32Peripheral Blood Stem Cell Transplantation 31Mycophenolic Acid 31Injections 31Idarubicin 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Practice Guidelines as Topic × Other hematologic neoplasm × Clear all
NCT03922035 2026-04-07

CBM588 in Improving Clinical Outcomes in Patients Who Have Undergone Donor Hematopoietic Stem Cell Transplant

City of Hope Medical Center

Phase 1 Active not recruiting
36 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT02962661 2026-01-07

Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

M.D. Anderson Cancer Center

Phase 1 Recruiting
72 enrolled
Other hematologic neoplasm

Heart Failure, Cardiomyopathies, Hematologic Neoplasms

NCT04060849 2024-11-08

Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY

Fred Hutchinson Cancer Center

Phase 1 Terminated
10 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT04439006 2023-12-26

Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization

Ohio State University Comprehensive Cancer Center

Phase 1 Completed
10 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Aplastic, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic Syndromes, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡